期刊文献+

宫颈癌介入化疗前后MMP-2和Ki67表达及意义 被引量:9

THE EXPRESSIONS AND THEIR SIGNIFICANCE OF MATRIX METALLOPROTEINASE-2 AND Ki67 IN CERVICAL CANCER BEFORE AND AFTER INTERVENTIONAL CHEMOTHERAPY
下载PDF
导出
摘要 目的探讨MMP-2和Ki67在宫颈癌介入化疗前后表达的变化及其对预测介入化疗敏感性的作用。方法在介入化疗前后用免疫组化方法测定46例宫颈癌组织MMP-2、Ki67蛋白的表达。结果宫颈癌介入化疗临床总有效率为78.26%,介入化疗有效率与临床期别无关(2χ=0.161,P>0.05)。介入化疗前后宫颈癌组织中MMP-2、Ki67蛋白的表达差异均有显著性(χ2=4.792、5.134,P<0.05)。介入化疗前MMP-2阳性者介入化疗有效率为82.86%,MMP-2阴性者介入化疗有效率为63.64%,两者比较差异无显著性(2χ=1.817,P>0.05);介入化疗前Ki67阳性者介入化疗有效率为83.78%,Ki67阴性者介入化疗有效率为55.56%,两者比较差异有显著性(χ2=7.521,P<0.05)。结论介入化疗能显著改变宫颈癌组织中MMP-2和Ki67蛋白的阳性表达率,抑制肿瘤细胞的增殖和浸润;介入化疗前检测宫颈癌组织中Ki67蛋白的表达可能用于预测介入化疗的临床疗效。 Objective To explore the expressions of MMP-2 and Ki67 in cervical cancer before and after interventional chemotherapy(IC),and its role in predicting the sensitivity of IC. Methods Expressions of MMP-2 and Ki67 protein in 46 samples of cervical cancer were checked by immunohistochemistry before and after IC. Results The total effective rate of IC was78.26%,which was not correlated with clinical stages(χ2=0.161,P0.05).The differences of expressions of MMP-2 and Ki67 before and after IC were significant(χ2=4.792,5.134;P0.05).Those with positive MMP-2 before IC,the effective power was 82.86%;for those with negative MMP-2,63.64%,no significant difference was found between them(χ2=1.817,P0.05).Those with positive Ki67 before IC,the effective power was 83.78%;and those with negative Ki67,55.56%,the difference between them being significant(χ2=7.521,P0.05). Conclusion Interventional chemotherapy could significantly change the positive expression rate of MMP-2 and Ki67 in cervical cancer tissue and suppress generation and infiltration of cancer cells.Before IC,a detection of Ki67 expression in the cancer tissue is possible to predict the efficacy of the therapy.
出处 《齐鲁医学杂志》 2010年第5期391-393,共3页 Medical Journal of Qilu
关键词 宫颈肿瘤 药物疗法 明胶酶A KI-67抗原 uterine cervical neoplasms drug therapy gelatinase A Ki-67 antigen
  • 相关文献

参考文献4

二级参考文献20

  • 1Kleiner DE,Stetler-Stevenson WG.Matrix metalloproteinases and metastasis.Cancer Chemother Pharmacol,1999,43(Suppl):S42-S51.
  • 2Parkin DM.Global cancer statistics in the year 2000.Lancet Oncol,2001,2(9):533-543.
  • 3Shin S,Sung BJ,Cho YS,et al.An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7.Biochemistry,2001,40(4):1117-1123.
  • 4Goodison S,Urquidi V,Tarin D.CD44 cell adhesion molecules.Mol Pathol,1999,52(4):189-196.
  • 5Hirata T,Fukuse T,Naiki H,et al.Expression of CD44 variantexon 6 in stage Ⅰ non-small cell lung carcinoma as a prognostic factor.Cancer Res,1998,58(6):1108-1110.
  • 6Speiser P,Wanner C,Tempfer C,et al.CD44 is an independent prognostic factor in early-stage cervical cancer.Int J Cancer,1997,74(2):185-188.
  • 7Adachi Y,Yamamoto H,Itoh F,et al.Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.Int J Cancer,2001,95(5):290-294.
  • 8Yamamoto H,Itoh F,Iku S,et al.Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas:clinicopathologic and prognostic significance of matrilysin expression.J Clin Oncol,2001,19(4):1118-1127.
  • 9Hofmann UB,Westphal JR,Van Muijen GN,et al.Matrix metalloproteinases in human melanoma.J Invest Dematol,2000,115(3):337-344.
  • 10ROSE P G. Locally advanced cervical cancer[J]. Curr Opin Obstet Gynecol, 2001,13 ( 1 ):65-70.

共引文献133

同被引文献97

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部